# Embryotoxicity and mixture effects of legacy PFAS in a human iPSC-based 3D model

**Authors:** Andreas Frederik Treschow, Elisa Martiny, Claudia Torero Gutierrez, Agnieszka Anna Niklas, Martin Scholze, Anne Marie Vinggaard, Maria João Valente

PMC · DOI: 10.1007/s10565-026-10137-8 · Cell Biology and Toxicology · 2026-01-19

## TL;DR

This study uses a 3D human cell model to show that a group of chemicals called PFAS can harm early development, especially heart cell formation.

## Contribution

The study introduces a 3D human iPSC-based model to assess embryotoxicity of PFAS mixtures and confirms concentration additivity in their effects.

## Key findings

- PFNA showed the highest embryotoxic potency among the tested PFAS.
- Mixture effects of PFAS followed concentration additivity across tested concentrations.
- PFOS affected the most embryonic development pathways, particularly those related to heart development.

## Abstract

Humans are continuously exposed to a wide array of exogenous chemicals via dietary intake, environmental sources, and the use of personal care products. This includes per- and polyfluoroalkyl substances (PFAS), a class of highly persistent compounds that have been associated with developmental effects in humans. This study assessed the effects of four legacy PFAS, namely PFOS, PFOA, PFNA and PFHxS, and mixtures thereof in the PluriLum assay, a 3D human induced pluripotent stem cell (hiPSC)-based model for embryotoxicity testing. We established the individual embryotoxic potencies of PFAS, with PFNA exhibiting the highest potency, followed by PFOS, PFOA and PFHxS. The four PFAS were evaluated in three reconstituted mixtures, prepared either to reflect identical potencies (“equipotent mixture”) or the average serum concentrations reported for the European adult or child population (“real-life mixtures”). Comparing observed versus predicted mixture responses demonstrated concentration additivity throughout the entire range of tested concentrations. Studies on uptake in 3D embryoid bodies revealed the highest bioaccumulation of PFOS, followed by PFNA, PFOA, and PFHxS. Moreover, less than 2% of the nominally added PFAS could be recovered in the embryoid bodies. RNA sequencing showed that relatively few genes were affected by PFOS, PFNA and PFOA, however expression of genes related to focal adhesion and functional pathways associated with cardiac, cardiomyocyte and muscle tissue development was significantly changed. Notably, PFOS affected the greatest number of embryonic development pathways. In conclusion, the four tested PFAS significantly impaired cardiomyocyte differentiation, indicating embryotoxicity. The combined responses were consistent with the concentration addition principle, supported by shared functional pathways and indicative of common sites of molecular action.

The online version contains supplementary material available at 10.1007/s10565-026-10137-8.

## Linked entities

- **Chemicals:** PFOS (PubChem CID 74483), PFOA (PubChem CID 9554), PFNA (PubChem CID 67821), PFHxS (PubChem CID 67734)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MYH7 (myosin heavy chain 7) [NCBI Gene 4625] {aka CMD1S, CMH1, CMYO7A, CMYO7B, CMYP7A, CMYP7B}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, ALDH1L2 (aldehyde dehydrogenase 1 family member L2) [NCBI Gene 160428] {aka mtFDH}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, Pfas (phosphoribosylformylglycinamidine synthase) [NCBI Gene 287420], PFAS (phosphoribosylformylglycinamidine synthase) [NCBI Gene 5198] {aka FGAMS, FGAR-AT, FGARAT, GATD8, PURL}, NKX2-5 (NK2 homeobox 5) [NCBI Gene 1482] {aka CHNG5, CSX, CSX1, HLHS2, NKX2.5, NKX2E}, MYH2 (myosin heavy chain 2) [NCBI Gene 4620] {aka CMYO6, CMYP6, IBM3, MYH2A, MYHSA2, MYHas8}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, ISL1 (ISL LIM homeobox 1) [NCBI Gene 3670] {aka ISLET1, Isl-1}, TBX18 (T-box transcription factor 18) [NCBI Gene 9096] {aka CAKUT2, PUJO}, RSPO1 (R-spondin 1) [NCBI Gene 284654] {aka CRISTIN3, RSPO}
- **Diseases:** Cytotoxicity (MESH:D064420), endocrine disorders (MESH:D004700), impaired neurodevelopment (MESH:D060825), function (MESH:D003291)
- **Chemicals:** ammonia (MESH:D000641), CHIR99021 (MESH:C473711), poly-T (MESH:D011071), perfluorohexanoic acid (MESH:C479228), carboxylic acids (MESH:D002264), ACN (MESH:C032159), BMC10 (-), Sodium selenite (MESH:D018038), dioxin (MESH:D004147), methanol (MESH:D000432), sulfonates (MESH:D000476), lipid (MESH:D008055), ammonium acetate (MESH:C018824), saline (MESH:D012965), PFHxS (MESH:C471071), water (MESH:D014867), perfluorobutane sulfonate (MESH:C539348), phospholipids (MESH:D010743), octanol (MESH:D000442), CO2 (MESH:D002245), Per- and polyfluoroalkyl substances (MESH:D005466), ATP (MESH:D000255), PFNA (MESH:C101816), TS (MESH:D014316), DMSO (MESH:D004121), guanidinium thiocyanate (MESH:C054436), Polystyrene (MESH:D011137), PFOS (MESH:C076994), EDTA (MESH:D004492), PFOA (MESH:C023036), phosphate (MESH:D010710)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** Y407E
- **Cell lines:** NKX2.5-T2A-Nluc-44.37 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_C0VT), BIONi010-C- — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_1E68), IMR90-1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_C434), BMC10 — Mus musculus (Mouse), Transformed cell line (CVCL_2I36)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847077/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847077/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847077/full.md

---
Source: https://tomesphere.com/paper/PMC12847077